Middle East & Africa Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others)
The Middle East & Africa infectious disease diagnostics market was valued at US$ 1,193.19 million in 2022 and is expected to reach US$ 1,576.80 million by 2030; it is estimated to grow at a CAGR of... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Middle East & Africa infectious disease diagnostics market was valued at US$ 1,193.19 million in 2022 and is expected to reach US$ 1,576.80 million by 2030; it is estimated to grow at a CAGR of 3.5% from 2022 to 2030.Rising Incidence of Infectious Diseases Drive Middle East & Africa Infectious Disease Diagnostics Market Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Program on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0-14 years. Also, ~1.5 million new HIV cases were reported globally in 2020. According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA). Middle East & Africa Infectious Disease Diagnostics Market Overview The Rest of Middle East & Africa includes Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya. Increasing demand for infectious disease diagnostics and growing technological advancement in clinical diagnostic technologies are boosting the market growth in the Middle Eastern and Africa. Moreover, the presence of major market players in the countries in the Rest of Middle East and Africa is fueling the growth of the market. for instance, Todos Medical Ltd. is a leading company in Israel that deals with providing life-saving diagnostic solutions for the early detection of various diseases. In 2021, the company has announced its first commercial antibody test for COVID-19. Thus, the presence of players offering products and end users related, the development and innovation of diagnostic solutions in various countries of the region is further likely to be responsible for supporting the overall growth of the market. Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Million) Middle East & Africa Infectious Disease Diagnostics Market Segmentation The Middle East & Africa infectious disease diagnostics market is segmented based on product, technology, application type, testing type, end user, and country. Based on product, the Middle East & Africa infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held the largest share in 2022. By technology, the Middle East & Africa infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The immunodiagnostics segment held the largest share in 2022. The molecular-based diagnostic techniques segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others. By application type, the Middle East & Africa infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held a larger share in 2022. By testing type, the Middle East & Africa infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held a larger share in 2022. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others. By end user, the Middle East & Africa infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held the largest share in 2022. Based on country, the Middle East & Africa infectious disease diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa infectious disease diagnostics market in 2022. Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, ACON Laboratories Inc, and DiaSorin SpA are some of the leading companies operating in the Middle East & Africa infectious disease diagnostics market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 2.2 Middle East & Africa Infectious Disease Diagnostics Market, by Geography (US$ Million) 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. Middle East & Africa Infectious Disease Diagnostics Market Landscape 4.1 Overview 4.2 Middle East & Africa PEST Analysis 5. Middle East & Africa Infectious Disease Diagnostics Market - Key Industry Dynamics 5.1 Market Drivers: 5.1.1 Rising Incidence of Infectious Diseases 5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease 5.2 Market Restraints 5.2.1 Inadequate Reimbursement Scenario 5.3 Market Opportunities 5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics 5.4 Future Trends 5.4.1 Rising Number of Product Approvals and Launches 5.5 Impact Analysis: 6. Infectious Disease Diagnostics Market - Middle East & Africa Market Analysis 6.1 Middle East & Africa Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030 7. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product 7.1 Overview 7.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 7.3 Kits & Reagents 7.3.1 Overview 7.3.2 Kits & Reagents: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 7.4 Instruments 7.4.1 Overview 7.4.2 Instruments: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 7.5 Software & Services 7.5.1 Overview 7.5.2 Software & Services: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 8. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology 8.1 Overview 8.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 8.3 Biosensor-based 8.3.1 Overview 8.3.2 Biosensor-based: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 8.4 Immunodiagnostics 8.4.1 Overview 8.4.2 Immunodiagnostics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 8.4.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 8.5 Molecular-Based Diagnostic Techniques 8.5.1 Overview 8.5.2 Molecular-Based Diagnostic Techniques: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 8.5.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 8.6 Clinical Biology 8.6.1 Overview 8.6.2 Clinical Biology: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 8.7 Others 8.7.1 Overview 8.7.2 Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 9. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type 9.1 Overview 9.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 9.3 Point-of-Care Testing 9.3.1 Overview 9.3.2 Point-of-Care Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 9.4 Laboratory Testing 9.4.1 Overview 9.4.2 Laboratory Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 10. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type 10.1 Overview 10.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 10.3 Human Testing 10.3.1 Overview 10.3.2 Human Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 10.3.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 10.4 Veterinary Testing 10.4.1 Overview 10.4.2 Veterinary Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 11. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User 11.1 Overview 11.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 11.3 Diagnostic Laboratories 11.3.1 Overview 11.3.2 Diagnostic Laboratories: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 11.4 Hospitals and Clinics 11.4.1 Overview 11.4.2 Hospitals and Clinics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 11.5 Research Institutes 11.5.1 Overview 11.5.2 Research Institutes: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 11.6 Homecare Settings 11.6.1 Overview 11.6.2 Homecare Settings: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 11.7 Others 11.7.1 Overview 11.7.2 Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million) 12. Middle East & Africa Infectious Disease Diagnostics Market - Country Analysis 12.1 Middle East & Africa Infectious Disease Diagnostics Market - Country Analysis 12.1.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country 12.1.1.1 Saudi Arabia 12.1.1.1.1 Overview 12.1.1.1.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 12.1.1.1.3 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 12.1.1.1.4 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 12.1.1.1.4.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 12.1.1.1.4.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 12.1.1.1.5 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 12.1.1.1.6 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 12.1.1.1.6.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 12.1.1.1.7 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 12.1.1.2 South Africa 12.1.1.2.1 Overview 12.1.1.2.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 12.1.1.2.3 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 12.1.1.2.4 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 12.1.1.2.4.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 12.1.1.2.4.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 12.1.1.2.5 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 12.1.1.2.6 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 12.1.1.2.6.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 12.1.1.2.7 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 12.1.1.3 UAE 12.1.1.3.1 Overview 12.1.1.3.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 12.1.1.3.3 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 12.1.1.3.4 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 12.1.1.3.4.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 12.1.1.3.4.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 12.1.1.3.5 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 12.1.1.3.6 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 12.1.1.3.6.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 12.1.1.3.7 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 12.1.1.4 Rest of Middle East & Africa 12.1.1.4.1 Overview 12.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 12.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million) 12.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million) 12.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million) 12.1.1.4.4.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million) 12.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million) 12.1.1.4.6 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million) 12.1.1.4.6.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million) 12.1.1.4.7 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million) 13. Industry Landscape 13.1 Overview 13.2 Growth Strategies Done by the Companies in the Market, (%) 13.3 Organic Developments 13.3.1 Overview 13.4 Inorganic Developments 13.4.1 Overview 14. Company Profiles 14.1 Abbott Laboratories 14.1.1 Key Facts 14.1.2 Business Description 14.1.3 Products and Services 14.1.4 Financial Overview 14.1.5 SWOT Analysis 14.1.6 Key Developments 14.2 Bruker Corp 14.2.1 Key Facts 14.2.2 Business Description 14.2.3 Products and Services 14.2.4 Financial Overview 14.2.5 SWOT Analysis 14.2.6 Key Developments 14.3 Cardinal Health Inc 14.3.1 Key Facts 14.3.2 Business Description 14.3.3 Products and Services 14.3.4 Financial Overview 14.3.5 SWOT Analysis 14.3.6 Key Developments 14.4 F. Hoffmann-La Roche Ltd 14.4.1 Key Facts 14.4.2 Business Description 14.4.3 Products and Services 14.4.4 Financial Overview 14.4.5 SWOT Analysis 14.4.6 Key Developments 14.5 Trinity Biotech Plc 14.5.1 Key Facts 14.5.2 Business Description 14.5.3 Products and Services 14.5.4 Financial Overview 14.5.5 SWOT Analysis 14.5.6 Key Developments 14.6 Danaher Corp 14.6.1 Key Facts 14.6.2 Business Description 14.6.3 Products and Services 14.6.4 Financial Overview 14.6.5 SWOT Analysis 14.6.6 Key Developments 14.7 Bio-Rad Laboratories Inc 14.7.1 Key Facts 14.7.2 Business Description 14.7.3 Products and Services 14.7.4 Financial Overview 14.7.5 SWOT Analysis 14.7.6 Key Developments 14.8 ACON Laboratories Inc 14.8.1 Key Facts 14.8.2 Business Description 14.8.3 Products and Services 14.8.4 Financial Overview 14.8.5 SWOT Analysis 14.8.6 Key Developments 14.9 DiaSorin SpA 14.9.1 Key Facts 14.9.2 Business Description 14.9.3 Products and Services 14.9.4 Financial Overview 14.9.5 SWOT Analysis 14.9.6 Key Developments 15. Appendix 15.1 About Us 15.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
The Insight Partners社のバイオテクノロジー分野での最新刊レポート
本レポートと同じKEY WORD(infectious disease)の最新刊レポートよくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|